Conference Short Courses*

Morning Short Courses

Monday, 2 November, 9:00 – 12:30

Engineering of Bispecific Antibodies

Nicolas Fischer, Ph.D., Head, Research, Novimmune SA
Michela Silacci, Director, Discovery Research, Covagen AG, one of the Janssen Pharmaceutical Companies of J&J

CHO Cell Engineering

Simon Fischer, Ph.D., Research Scientist, Institute of Applied Biotechnology, University of Applied Sciences Biberach
Zhiwei Song, Ph.D., Principal Scientist, Bioprocessing Technology Institute, A*STAR
Additional Instructors to be Announced

Protein Purification Strategies: Dealing with Proteins that are Prone to Aggregate

Mario Lebendiker, Ph.D., Head, Protein Purification Facility, Wolfson Centre for Applied Structural Biology, The Hebrew University of Jerusalem

Mutation and Selection Strategies for Multi-Parameter Antibody Optimization

William (Jonny) Finlay, Ph.D., Senior Director, Development Lab, Global Biotherapeutics Technologies, Pfizer BioTx Research & Development
Orla Cunningham, Ph.D., Associate Director, External Global Biotherapeutics Technologies, Pfizer, Inc.

Dinner Short Courses

Thursday, 5 November, 18:00 – 21:00

Troubleshooting and Engineering of Antibody Constructs

Jonas V. Schaefer, Ph.D., Head, High-Throughput Laboratory, Biochemistry, University of Zurich
Julia Neugebauer, Ph.D., Associate Director, Discovery Programs, Morphosys AG

Antibody-Based Cancer Immunotherapy

Christian Klein, Ph.D., Head, Oncology Programs, Roche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich
Jos Melenhorst, Ph.D., Director, Product Development & Correlative Sciences Labs, University of Pennsylvania

The Challenge of Protein Aggregation and Formation of Sub Visible Particles in the Development of Biopharmaceuticals

Tudor Arvinte, Ph.D., Chairman & CEO, Therapeomic, Inc.

Advanced Techniques for Characterization of Protein Aggregates, Particulates and Contaminants

Matthew Brown, Ph.D., Life Science Specialist, Malvern Instruments
Amber Fradkin, Ph.D., Associate Director, Research & Development, KBI Biopharma
Stacy Kenyon, Ph.D., Scientist, Bioscience Development Initiative, Malvern Instruments

*Separate registration required for short courses